Key facts
- This page summarizes Robert Lisicki's Form 4 filing for Zura Bio Ltd (ZURA).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 21 Jun 2024, 18:10.
Robert Lisicki - 18 Jun 2024 Form 4 Insider Report for Zura Bio Ltd (ZURA)
- Form type
- 4
- Accepted by SEC
- 21 Jun 2024, 18:10:12 UTC
- Previous filing
- 26 Jan 2024
- Next filing
- 11 Dec 2024
- SEC filing
- View on sec.gov
- Reporting owner signature
- /s/ Robert Lisicki
Source evidence
5 source fields
Reporting owner
1 detail
Key filing fact
Robert Lisicki filed Form 4 for Zura Bio Ltd (ZURA) on 21 Jun 2024.
Change
- Previous filing in this sequence was filed on 26 Jan 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ZURA
transaction
Derivative
Employee Share Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +1,050,000
- Change %
- Price
- $0.000000
- Shares after
- 1,050,000
- Date
- 18 Jun 2024
- Ownership
- Direct
- Underlying class
- Class A Ordinary Shares
- Underlying amount
- 1,050,000
- Exercise price
- $3.38
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
One fourth (1/4th) of the shares subject to the option award shall vest on June 18, 2025, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.